Two viruses in hatchery seabass: what can be inferred?

A 2026 paper about samples collected in 2016

The publication date is recent; the hatchery event is not. Louboutin and colleagues examined European seabass (Dicentrarchus labrax) fingerlings sampled in June and September 2016. The fish were approximately four centimetres long and came from a hatchery reporting health disorders and low mortality. Some had raised whitish changes on the fins or flanks and distended abdomens. These observations prompted investigation, but they are not a diagnostic pattern that can be assigned to either newly described virus.

The team combined examinations of affected fish with cell culture, sequencing and phylogenetic analysis. It characterised a pesti-like virus, DLPLV, and an astro-like virus, DLALV. DLPLV was found in both culture supernatant and organ homogenate, whereas the astro-like sequence was identified in a homogenate. These are distinct lines of evidence. Treating the two detections as though both agents had been isolated and tested in the same way would overstate the result.

Detection, exposure and causation

An inoculated cell line developed a cytopathic effect, and sequencing identified the viral genomes. Finding viral material in affected fish supports an association with the sampled event. It does not show that either agent produced every lesion seen at the hatchery. Other agents and conditions can coexist in a lot, and the timing of sampling matters.

The researchers attempted experimental transmission. Direct or waterborne contact with fish showing signs produced only sporadic, transient signs in healthy fish. Bath exposure to DLPLV alone caused 8–16% mortality in fish 162 days after hatching under the study conditions. That percentage belongs to the experimental groups. It cannot be applied to another hatchery, another age class or the original outbreak as a forecast.

Seroneutralisation assays found a DLPLV-specific humoral response in the groups tested. This strengthens evidence that fish encountered the virus. It does not close the causal argument for the entire clinical picture. The authors explicitly describe how difficult it was to reproduce the hatchery presentation, a warning against reducing a complex field problem to one positive test.

Set up a useful hatchery investigation

For staff facing an unusual cluster of signs, the most valuable first action is to preserve context. Record the affected lot, its origin and age, the date and progression of signs, mortality over time and movements between units. Document water conditions and husbandry changes alongside the clinical timeline. A vial labelled only with a species name cannot answer how an event unfolded.

Clinical examination and necropsy help determine which tissues and additional tests are needed. The published investigation included bacteriological and histological work as well as virology. Discuss sampling with the diagnostic laboratory while representative fish and a reliable chronology are still available. Sample condition, tissue choice and timing influence the meaning of both positive and negative findings.

The molecular tools developed in the study may support targeted detection in future cases. Their question should be stated before testing: is the agent present in these samples from this lot, and how does that result fit the broader investigation? A positive PCR result does not automatically measure viable virus, transmission or attribution of lesions. A negative result cannot exclude infection beyond the tested material and circumstances.

Laboratories also need a record of which assay was used and what material it was validated to examine. Results from different methods should not be treated as interchangeable merely because they refer to the same proposed agent.

Decisions while the cause remains open

Maintaining lot traceability and reviewing avoidable movement of fish, equipment and water are proportionate steps during an investigation. The aim is to keep observations interpretable and limit opportunities for spread if an infectious agent is involved. Neither step requires a premature diagnosis of DLPLV or DLALV. Local biosecurity decisions still need to fit the actual hatchery layout and its existing procedures.

The paper does not establish a treatment protocol, a universal threshold for interpreting a viral result or a consumer health risk. Laboratory findings should be considered together with clinical observations, other test results and the event timeline. If a later case differs by species, stage or presentation, the findings from these fingerlings should not be transferred without qualification.

Limits and conclusion

This study broadens the list of agents that a diagnostic investigation may consider in European seabass hatcheries. It also shows the limits of an agent-centred explanation: experimental exposure reproduced only part of the field picture. Describing a new sequence and demonstrating that it caused a specific hatchery syndrome are separate achievements.

A practical response is therefore to improve the information accompanying each sample. Clear lot records, appropriately selected tissues and a discussion of alternative explanations will make targeted viral testing more useful than an isolated positive or negative result.

Vetofish support

Vetofish can help hatchery teams organise observations and sampling when fingerlings develop unexplained signs, then interpret results in the context of the lot. Our diagnostic services support aquaculture teams without assigning a cause before the investigation is complete.